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1975). Second, it must explain how the VSV polymeraseThe rhabdovirus vesicular stomatitis virus (VSV) en-
traverses the intergenic junctions discontinuously bycapsidates all the enzymes required for the synthesis
skipping over two to four nucleotides in the templateand processing of five mRNAs encoding the N, P, M, G,
strand (McGeoch, 1979; Keene et al., 1980; Rose, 1980).and L proteins, respectively. These transcripts are
Current knowledge of these two processes is summa-capped at their 5* ends and polyadenylated at their 3*
rized below.ends. The VSV polymerase, which is composed of the L
and P polypeptides, initiates at the 3* end of the 11-kb
CAPPING OF VSV mRNAsviral genomic RNA and sequentially synthesizes a 47-
nucleotide noncoding leader RNA and the five mRNAs The triphosphate bridge of the GpppA cap of VSV
according to their order in the template: leader-N-P-M- mRNAs is composed of two phosphates derived from
G-L (Fig. 1) (Ball and White, 1976; Abraham and Banerjee, GDP and one phosphate derived from an AMP residue
1976; Iverson and Rose, 1981; Emerson, 1982). The 3*- in the RNA. This contrasts with the conventional mecha-
terminal 15–17 nucleotides of the genomic RNA suffice nism of cap formation (utilized by vaccinia virus, reovirus,
in specifying accurate initiation by VSV polymerase in and all eukaryotic cells) in which GMP is transferred to
vitro (Smallwood and Moyer, 1993). a 5* diphosphate end of an RNA chain. In the standard
For more than 20 years, investigators have sought to capping reaction, only RNAs initiated de novo can be
account for the polarity of VSV transcription. Two princi- capped by the enzyme RNA guanylyltransferase, which
pal models have been advanced entailing either (i) reacts with GTP to form a covalent enzyme-GMP interme-
nucleolytic processing of a singly initiated precursor RNA diate, and then transfers this GMP to the 5* diphosphate
or (ii) sequential reinitiation by RNA polymerase at each RNA acceptor (Shuman, 1995). The inability to detect co-
mRNA 5* end. The reinitiation model itself comes in two valent attachment of a 32P-labeled guanine nucleotide to
flavors: (iia) a single RNA polymerase starts at the 3* end a VSV virion polypeptide in vitro argues that a novel reac-
of the genomic template and sequentially synthesizes all tion mechanism applies. Furthermore, none of the se-
five mRNAs and (iib) different polymerase molecules are quence motifs characteristic of covalent nucleotidyl
poised at each intergenic junction and are activated in transferases are found in VSV-encoded proteins (Shu-
a wave-like fashion to initiate synthesis of a single mRNA man and Schwer, 1995).
by completion of transcription by the upstream polymer- One argument in favor of the nucleolytic processing
ase. The merits of each model have been considered in model is that RNA cleavage would generate a 5* mono-
prior reviews (Ball and Wertz, 1981; Banerjee, 1987). My phosphate RNA end that would be capped with GDP. If
intention in this article is to advance a different view of the ends of VSV mRNA derived instead from de novo
VSV transcription, focusing on reaction chemistry, which initiation, they would have 5* triphosphate termini, which
takes into account recent advances in our understanding would have to be hydrolyzed to monophosphate ends in
of transcription elongation by DNA-dependent RNA poly- order to be capped. The leader RNA, which clearly does
merases. The key tenet of the model, which posits a arise via de novo initiation, maintains a 5* triphosphate
single transcription initiation event, is that VSV RNA poly- or 5* diphosphate terminus and is not capped. Accord-
merase itself catalyzes the coupled scission and capping ingly, if initiated ends are trimmed to monophosphates
of a nascent RNA at each intergenic junction. and capped, this must be specific to the five mRNAs.
Any model of VSV mRNA synthesis must contend with It is worth emphasizing that there is no direct evidence
two mechanistic constraints. First, it must account for for the existence of any activity within VSV particles that
can transfer GDP to an exogenous 5* monophosphate-the unusual chemistry of 5* capping (Abraham et al.,
1
0042-6822/97 $25.00
Copyright q 1997 by Academic Press
All rights of reproduction in any form reserved.
AID VY 8305 / 6a22$$$381 12-04-96 09:35:34 vira AP: Virology
2 STEWART SHUMAN
for mRNA synthesis in which the polymerase skips over
the intergenic gap and begins a new chain at the AACAG
element. It has been observed that VSV particles synthe-
size triphosphate- and diphosphate-terminated oligonu-
cleotides containing 5* sequences characteristic of VSV
mRNAs (Testa et al., 1980; Chanda et al., 1980). These
oligonucleotides accumulate at early times, especially
when one or more NTP precursors are omitted from the
in vitro transcription reaction, and their synthesis ap-
pears not to be contingent on prior synthesis of the
leader. This finding inspired the multiple polymerase
start-stop theory (model iib described above), because it
implied that polymerases were positioned at internal
sites on the template. However, there is no convincing
FIGURE 1 proof that these oligonucleotides are bona fide precur-
sors to mature full-length mRNA; indeed, available evi-
dence indicates they are not (Lazzarini et al., 1982). More-
terminated RNA substrate. Thus, capping of VSV RNA
over, the short oligonucleotides observed by Testa et al.
ends appears to be obligately coupled to VSV RNA syn-
and Chanda et al. were all uncapped. This is surprising
thesis. (This is not the case for reovirus and vaccinia
and appears to argue against the capping pathway in-
virus particles, which can cap exogenous oligonucleotide
voked for reinitiation-based models, whereby polyphos-
acceptors.) Moreover, there is no direct evidence that
phate mRNA ends are processed to monophosphates
5* monophosphate termini are ever formed during VSV
and then guanylated. Different results were obtained by
mRNA synthesis. Hence, any hypothetical monophos-
Piwnica-Worms and Keene (1983), who detected in vitro
phate-terminated nucleolytic products must be capped
synthesis of 5* capped mRNA oligonucleotides from the
so rapidly as to be undetectable. Alternatively, as pro-
N and P genes. Sequential appearance of these capped
posed below, VSV uses a nonhydrolytic mechanism to
species during synchronous transcription suggested a
cleave the mRNA precursor.
single entry model of mRNA synthesis, but left unre-
solved whether the 5* ends of mRNAs were generated
EVENTS AT THE INTERGENIC JUNCTIONS
by processing or initiation.
Key regulatory events in VSV mRNA biogenesis occur
at the intergenic junctions. The plus-strand sequences A NOVEL MECHANISTIC HYPOTHESIS FOR VSV
of all six junctions of the Indiana serotype of VSV are mRNA SYNTHESIS
shown in Fig. 1. Polyadenylation occurs via slippage of
the VSV transcriptase on a run of seven U residues in I suggest a novel mechanism of VSV transcription that
accounts for discontinuous transcription across the in-the genomic RNA template (McGeoch, 1979; Schubert et
al., 1980). The absence of this plus-strand A-run at the tergenic junction and for the formation of the 5* cap. The
model posits a single site of transcription initiation of theleader-N junction (Fig. 1) accounts for the fact that the
leader RNA lacks a poly(A) tail. A priori, slippage synthe- leader RNA and focuses on the chemical and conforma-
tional steps of the VSV polymerase elongation complexsis of poly(A) can only occur if polymerase elects not to
incorporate the next nonadenylate nucleotide 3* of the when it encounters the intergenic regions.
The proposed behavior of the viral polymerase at thetemplated run of seven adenylates. Hence, the polymer-
ase must be programmed to do this during viral mRNA leader-N junction is illustrated in Fig. 2. VSV transcriptase
that has initiated leader synthesis at the 3* end of thesynthesis, but not during replicative synthesis, when un-
interrupted full-length plus-strand RNA is produced. genomic template elongates to position C47 or A46,
which correspond to the predominant 3* ends of theThe 5* ends of all VSV mRNAs contain the sequence
AACAG. Remarkably, the two nucleotides between the leader RNA. The polymerase then arrests forward move-
ment and fails to incorporate the next templated residue.poly(A) sequence and the 5* end of the next mRNA are
not represented in mature mRNA (McGeoch, 1979; Rose, Instead, the nascent RNA slips forward within the ternary
complex such that the last 2 or 3 residues of the leader1980). Similarly, the three or four residues 5*-(C)UUU that
separate the AA(C)-3* end of the leader RNA and the 5* (AA-3* or AAC-3* ) base pair with the template sequence
3*-UU or 3*-UUG at the start of the N mRNA. In thisend of the N mRNA are not incorporated during mRNA
synthesis (Colonno and Banerjee, 1978; Keene et al., configuration the pentapurine sequence immediately up-
stream in the leader RNA can base pair with the template1980). Of course, these intercistronic spacers are copied
faithfully during replicative plus strand synthesis. This across a four-nucleotide unpaired RNA loop in the tem-
plate strand (Fig. 2, step 2). Forward slippage of the na-state of affairs would appear to favor a reinitiation model
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on the ApA bond spanning the dinucleotide loop to yield
a capped mRNA 5* end on the downstream mRNA and
a mature 3* poly(A) tail on the upstream mRNA (Fig. 3,
step 4). This would relieve the conformational strain and
reposition the catalytic center of the polymerase over the
3* hydroxyl of the capped oligonucleotide, at which point
elongation synthesis would ensue.
I argue that the rate-limiting step in overcoming the
elongation block at the intergenic junction is either for-
ward slippage of the nascent RNA or GDP-mediated na-
scent chain cleavage. Failure to accomplish either of
these events would impede further elongation. One need
only invoke less than perfect efficiency of these transi-
tions to account for the observed 30% attenuation of
transcription at each intergenic junction (Iverson and
Rose, 1981). A critical component of the model is the
requirement for base-pairing across an intergenic gap
(of 2 to 4 nucleotides). Without the potential for such
base-pairing, the polymerase will terminate synthesis.
FIGURE 2 This would be the case at the 3* end of the L mRNA.
Here, there is no 3*-UU nucleotide immediately down-
stream with which the poly(A) tail can pair. The nearest
scent RNA is not accompanied by forward movement of 3*-UU sequence in the template is located 12 nucleotides
the catalytic center of the polymerase, which would be away and is not part of a consensus 3*-UUGUC element
poised over the ApA internucleotide bond at the margins that encodes the 5* ends of VSV mRNAs.
of the loop. I posit that this is a strained conformation
for the polymerase elongation complex, assumption of REACTION CHEMISTRY
which triggers polymerase-mediated attack of GDP
Although the chemistry invoked in this model of RNAacross the ApA dinucleotide. In this reaction, the b-phos-
processing may appear unusual to many RNA virologists,phate of GDP forms a phosphoanhydride bond to the
there is ample precedent for nascent RNA cleavage dur-scissile phosphate and the 3* OH of the leader RNA is
ing transcription elongation by DNA-dependent RNAexpelled as the leaving group. The reaction generates a
polymerases. E. coli RNA polymerase (Surratt et al., 1992,5* capped oligonucleotide corresponding to the 5* end
of the N mRNA. Upon cleaving the nascent chain, the
strain imposed by loop formation would be relieved and
the catalytic center of the polymerase would be reposi-
tioned over the 3* hydroxyl of the capped oligonucleotide
such that it could resume elongation of the capped N
primer-template.
The proposed behavior of the polymerase at the
mRNA–mRNA junctions is illustrated in Fig. 3. Here, the
elongating polymerase copies the oligoadenylate se-
quence and then arrests forward movement prior to in-
corporation of the next non-A nucleotide. The elongation
complex then slips backward along the template and
incorporates AMP. Multiple cycles of slippage and AMP
incorporation on the U-run in the template strand gener-
ate a poly(A) tail as proposed previously (Schubert et
al., 1980). After poly(A) synthesis, the nascent RNA slips
forward such that the last two nucleotides of the poly(A)
tail now base-pair with the template sequence 3*-UU
corresponding to the 5* end of the downstream mRNA.
In this configuration the poly(A) can still base pair with
the template across an unpaired dinucleotide in the tem-
plate strand (Fig. 3, step 3). As posited for the leader-N
FIGURE 3junction, this conformation would trigger attack of GDP
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Chamberlin, 1994), eukaryotic RNA polymerase II zymes release the downstream 5* monophosphate or 5*
triphosphate-terminated oligonucleotide cleavage prod-(Reines, 1992; Izban and Luse, 1992) and RNA polymer-
ase III (Whitehall et al., 1994), and vaccinia virus RNA uct and resume elongation from the 3* OH terminus on
the upstream RNA, whereas I posit that VSV polymerasepolymerase (Hagler and Shuman, 1993) are all capable
of catalyzing hydrolytic cleavage of the nascent RNA at releases the upstream RNA and elongates from the
capped primer. The DNA-dependent RNA polymerasesvarious intervals from the 3* growing point of the chain
to yield 3* hydroxyl and 5* phosphate-terminated prod- are believed to have a tight RNA binding site located at
a distance from the growing point of the chain. Perhapsucts. The inciting event for nascent chain cleavage is
believed to be an elongation block followed by the as- the VSV polymerase has a tight binding site for the tem-
plate RNA in advance of the nascent chain, in whichsumption of a conformation in which the catalytic center
of the polymerase is positioned over an internal phospho- case the relaxation of conformational strain imposed by
the RNA loop would allow the active site of the VSVdiester bond rather than the growing point of the chain.
The distance between the cleavage site and the 3* end polymerase to move from the site of cleavage/capping
back to the 3* OH terminus of the capped primer.of the chain is quite variable (from 1 to 17 nucleotides)
and depends on the source of the polymerase, the pres- The model for VSV mRNA 5* end formation differs from
any known mechanism of capping in several respects.ence of cleavage-stimulatory factors, and the circum-
stances that elicit the elongation block (Borukhov et al., First, it dispenses with the need for a capping enzyme
distinct from RNA polymerase. Second, it invokes GDP as1993; Feng et al., 1994; Izban and Luse, 1993; Gu and
Reines, 1995; Deng and Shuman, 1996). the substrate for guanylation rather than GTP. Although
Abraham et al. (1975) demonstrated that the a and bRudd et al. (1994) have shown that arrested pol II elon-
gation complexes catalyze nucleophilic attack by pyro- phosphates of exogenous GTP are incorporated into the
VSV cap structures, it is not obvious that GTP is thephosphate (PPi) on the same internal phosphodiester
bonds that are prone to hydrolytic cleavage. This reaction immediate cap donor. As pointed out by Testa et al.
(1980), an accurate description of the cap donor is com-yields a 5* triphosphate-terminated cleavage product.
Because RNA polymerization occurs via PPi displace- plicated by the presence in VSV virions of nucleoside
triphosphate phosphohydrolase and nucleoside diphos-ment, this finding suggests strongly that the nascent
chain cleaving reaction occurs at the RNA polymerase phate kinase activities.
active site. This mandates a revision of accepted wisdom
that all RNA triphosphate termini derive from de novo THE EXCEPTION THAT PROVES THE RULE
initiation.
The proposal that the VSV elongation complex is capa- In my model, traversal of the junction during mRNA
synthesis is accomplished by forward slippage such thatble of catalyzing attack by GDP at an internal phospho-
diester to form a 5* cap invokes the same reaction chem- the intervening dinucleotide is not transcribed. However,
at very low frequency, the VSV polymerase will emergeistry, but imposes additional specificity for a guanosine
moiety linked to the pyrophosphate. Or rather, it imposes from the slippage mode of reiterative AMP incorporation
and resume elongation into the downstream cistron. Thisa need to discriminate in favor of GDP and against non-
guanosine nucleoside diphosphates. Indeed, I would results in the production of polycistronic transcripts inter-
rupted by long poly(A) tails (Herman et al., 1978). Remark-suggest that the VSV transcriptase is capable of using
PPi as a nucleophile and that such a reaction is the ably, these polycistronic transcripts contain the continu-
ous intergenic sequence 5*-CUAACAG linked directly tosource of the triphosphate-terminated mRNA ends gen-
erated during in vitro synthesis of VSV mRNAs. In this the poly(A) tail (Herman et al., 1980). Hence, the polymer-
ase can copy the normally missing intergenic CU dinucle-view, capped mRNAs and triphosphate mRNA termini
are generated by the same polymerase-catalyzed reac- otide and continue synthesis in the absence of forward
slippage, albeit not very well. The critically instructivetion and there is no potential for any precursor–product
relationship between them. The observations that tri- point is that these polycistronic transcripts containing
the intercistronic dinucleotide are not processed andphosphate-terminated mRNA oligonucleotides are not
chased into full-length mRNAs suggests that the tran- capped by the elongating polymerase. No polycistronic
mRNAs lacking the dinucleotide are detected. This pre-scriptase aborts elongation when the mRNA 5* ends are
uncapped. Smallwood and Moyer (1993) found that a cipitates the conclusion that the only RNAs that can be
capped are those that adopt the strained conformationvast molar excess of triphosphate-terminated leader oli-
gonucleotides (8–12 nucleotides in length) is generated resulting from forward slippage across the intergenic
space. In other words, strain induced by the unpairedduring abortive initiation-elongation at the 3* end of the
genomic template. template strand loop is required to trigger attack of GDP
on the nascent RNA. Needless to say, this would notThe principal distinction between nascent RNA cleav-
age by DNA-dependent RNA polymerases and the reac- occur during the continuous elongation mode that char-
acterizes replicative plus-strand synthesis.tion I propose for VSV is that the DNA-dependent en-
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the nascent G mRNA could be repositioned across what
effectively amounts to a 2-nucleotide gap (Fig. 4). The
spacer sequence of the Hazelhurst subtype lacks this
potential for stem–loop formation at the margins of the
21-mer gap; however, there is the potential to bring the
pseudo element in proximity to the oligo(A) sequence
via formation of a 3-bp stem structure in the intervening
template sequence 3*-CUAAAUUA.
In conclusion, I have presented a new view of VSV
mRNA synthesis that provides a unified explanation for
many of the (sometimes contradictory) experimental find-
ings that have been reported. This model engenders a
series of predictions concerning the RNA sequence ele-
ments essential for cotranscriptional capping that should
be eminently testable now that VSV can be propagated
entirely from cDNA clones (Lawson et al., 1995; Whelan
et al., 1995). Indeed, Schnell et al. (1996) have used this
approach to show that a 23-nucleotide element com-
posed of the 3* 11 nucleotides of the upstream mRNA,
the intercistronic dinucleotide, and the 5* 10 nucleotides
of the downstream mRNA (i.e., the sequence spanning
the shaded boxes in Fig. 1) is sufficient to drive stable
FIGURE 4 expression of a downstream reporter gene within a VSV
recombinant virus. All predictions of the model can be
tested by combining reverse genetics with an analysisTHE EXCEPTION THAT BENDS THE RULE
of VSV mRNA synthesis and processing in reconstituted
in vitro systems that consist of recombinant VSV proteinsThe sequences of three of the inter-mRNA junctions
of the New Jersey serotype of VSV are similar to those and are programmed by synthetic RNA templates
(Smallwood and Moyer, 1993; Mathur et al., 1996).of the Indiana serotype, i.e., the template elements en-
coding the proximal poly(A) tail and the 5* end of the
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